Here’s a compliant 160-character meta description based on the article content: Columbia Threadneedle reports strong Q2 ...

Viking Therapeutics offers a speculative opportunity, driven by its promising obesity drug pipeline. Click here to read more ...

Explore Blink Charging Co.'s Q2 2025 earnings call insights, highlighting 73% product revenue growth, cost reductions, Zemetric acquisition, and plans ...

Blink Charging Co. ( NASDAQ: BLNK) Q2 2025 Earnings Conference Call August 18, 2025 4:30 PM ET Michael Bercovich - Corporate Participant Michael C. Battaglia - President, CEO & Director Vitalie Stelea ...

Columbia Threadneedle Investments reports a 3.87% Q2 return for its Flexible Capital Income Fund. Explore how convertibles ...

BMNR's pivot to an Ethereum treasury model offers leveraged upside, aiming to acquire 5% of all ETH and trade at a premium to ...

Discover Fabrinet's record-breaking Q4 2025 performance with $910M revenue and robust growth in telecom and datacom.

Columbia Threadneedle Investments reports Q2 underperformance for its Dividend Opportunity Fund amid tech and energy drags.

SPYV offers a defensive growth profile with lower risk, key AI-driven growth exposure, and potential for better risk-adjusted ...

Profound Medical Corp.’s TULSA-PRO system can treat BPH-related symptoms with safe, minimally invasive procedures. Click here ...

BHP reported its smallest annual underlying profit in five years, as iron ore prices remained under pressure due to ...

Glencore filed applications with Argentina's government for two copper projects with a combined $13B-plus in planned capital ...